Clinical Trials
8
Active:0
Completed:7
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Hepatitis C Diagnosis to Treatment Management
Completed
- Conditions
- Hepatitis C
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Epividian
- Target Recruit Count
- 1063
- Registration Number
- NCT05725109
- Locations
- 🇺🇸
AIDS Healthcare Foundation, Los Angeles, California, United States
Hepatitis C Screening Alerts
Completed
- Conditions
- Hepatitis C
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Epividian
- Target Recruit Count
- 125706
- Registration Number
- NCT05710120
- Locations
- 🇺🇸
AIDS Healthcare Foundation, Los Angeles, California, United States
External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- Epividian
- Target Recruit Count
- 141
- Registration Number
- NCT05495204
- Locations
- 🇺🇸
Epividian, Durham, North Carolina, United States
COVID-19 Quantitative Antibody Titers & Booster Vaccinations
Completed
- Conditions
- COVID-19COVID-19 VaccinesImmunogenicity, Vaccine
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Epividian
- Target Recruit Count
- 825
- Registration Number
- NCT05104359
- Locations
- 🇺🇸
AHD Manhattan Midtown HCC, New York, New York, United States
Cabenuva Injection Tracking in CHORUS
Not Applicable
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2021-04-28
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- Epividian
- Target Recruit Count
- 37
- Registration Number
- NCT04863261
- Locations
- 🇺🇸
AIDS Healthcare Foundation, Los Angeles, California, United States
- Prev
- 1
- 2
- Next
News
No news found